Indeed, GLMs attributed a much higher importance to two comorbidities (cardiovascular pathologies and neoplasia in the last 5 years), followed by only one saturation value (spO2.in.FA), two symptoms (presence of Dyspnea, and Vomiting/Nausea), and only C-Reactive Protein was used among the laboratory variables; the other variables had negligible importance. This evidence concerns the gene CRP and neoplasm.